VAERS reports by lot

Pfizer COVID-19 lot FP7136: VAERS reports

318 VAERS reports list lot FP7136 as a Pfizer COVID-19 vaccine, received between 2022-10-08 and 2024-03-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
318
Reports
2%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2520%
General / Systemic (non-local)1916%
Gastrointestinal1613%
Respiratory1411%
Injection-site / Local reaction1311%
Cardiac / Cardiovascular1210%
Dermatological (non-injection-site)119%
Musculoskeletal54%
Allergic / Anaphylactic32%
Psychiatric / Neuropsychiatric32%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California41
New Jersey40
Michigan31
Vermont19
Texas14
North Carolina13
Illinois12
Nebraska11
Virginia11
Florida8
New York7
New Hampshire7

Reports by month received

2022-101
2022-121
2023-0173
2023-0285
2023-0335
2023-0452
2023-0525
2023-0628
2023-0811
2023-091
2023-104
2023-111
2024-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.